S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
CGC   22.65 (-7.78%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
TSLA   564.82 (-1.29%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
NFLX   353.16 (+1.02%)
PRI   122.53 (-2.41%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
CGC   22.65 (-7.78%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
TSLA   564.82 (-1.29%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
NFLX   353.16 (+1.02%)
PRI   122.53 (-2.41%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
CGC   22.65 (-7.78%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
TSLA   564.82 (-1.29%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
NFLX   353.16 (+1.02%)
PRI   122.53 (-2.41%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
CGC   22.65 (-7.78%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
TSLA   564.82 (-1.29%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
NFLX   353.16 (+1.02%)
PRI   122.53 (-2.41%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
Log in

OTCMKTS:STLT - Spotlight Innovation Stock Price, Forecast & News

$0.0094
0.00 (0.00 %)
(As of 01/24/2020 04:00 PM ET)
Today's Range
$0.01
Now: $0.01
$0.01
50-Day Range
$0.00
MA: $0.01
$0.01
52-Week Range
$0.00
Now: $0.01
$0.03
Volume27,299 shs
Average Volume16,129 shs
Market Capitalization$336,144.00
P/E RatioN/A
Dividend YieldN/A
Beta0.33
Spotlight Innovation Inc., a pharmaceutical company, acquires and develops proprietary therapies to address unmet medical needs with an emphasis on rare, emerging, and neglected diseases. It identifies in-licensing opportunities and manages product development through partnerships with universities, medical schools, contract research organizations, and contract manufacturing organizations, as well as pursues product commercialization opportunities, including out-licensing and strategic partnerships. The company is developing Crotoxin, which is in Phase I clinical study for the treatment of cancer. It also develops various compounds for the treatment of viral infections, including Zika virus infection; and products derived from cobra venom to treat chronic pain. Spotlight Innovation Inc. has a license agreement with Indiana University Research and Technology Corporation to commercialize STL-182, an orally-available small molecule that might have therapeutic potential for treating spinal muscular atrophy. The company is based in Urbandale, Iowa.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:STLT
CUSIPN/A
Phone515-274-9087

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees4
Market Cap$336,144.00
Next Earnings DateN/A
OptionableNot Optionable

Receive STLT News and Ratings via Email

Sign-up to receive the latest news and ratings for STLT and its competitors with MarketBeat's FREE daily newsletter.


Spotlight Innovation (OTCMKTS:STLT) Frequently Asked Questions

What is Spotlight Innovation's stock symbol?

Spotlight Innovation trades on the OTCMKTS under the ticker symbol "STLT."

Has Spotlight Innovation been receiving favorable news coverage?

News stories about STLT stock have trended somewhat positive recently, according to InfoTrie Sentiment. The research firm scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Spotlight Innovation earned a news sentiment score of 1.3 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the next few days. View News Stories for Spotlight Innovation.

Who are some of Spotlight Innovation's key competitors?

What other stocks do shareholders of Spotlight Innovation own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Spotlight Innovation investors own include Halliburton (HAL), Immune Pharmaceuticals (IMNP), Globalstar (GSAT), Genocea Biosciences (GNCA), Second Sight Medical Products (EYES), EVINE Live (EVLV), Auris Medical (EARS), Dynavax Technologies (DVAX), DURECT (DRRX) and Capstone Turbine (CPST).

Who are Spotlight Innovation's key executives?

Spotlight Innovation's management team includes the folowing people:
  • Mr. John Michael Krohn, Chairman, CEO, Pres, COO & Interim CFO (Age 60)
  • Mr. Cristopher Grunewald, Consultant (Age 46)
  • Mr. Rene Erickson, VP of Corp. Communications
  • Dr. Geoffrey M. Laff Ph.D., Sr. VP of Bus. Devel.

How do I buy shares of Spotlight Innovation?

Shares of STLT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Spotlight Innovation's stock price today?

One share of STLT stock can currently be purchased for approximately $0.01.

How big of a company is Spotlight Innovation?

Spotlight Innovation has a market capitalization of $336,144.00. Spotlight Innovation employs 4 workers across the globe.View Additional Information About Spotlight Innovation.

What is Spotlight Innovation's official website?

The official website for Spotlight Innovation is http://www.spotlightinnovation.com/.

How can I contact Spotlight Innovation?

Spotlight Innovation's mailing address is 11147 AURORA AVENUE AURORA BUSINESS PARK BUILDING 3, URBANDALE IA, 50322. The company can be reached via phone at 515-274-9087 or via email at [email protected]


MarketBeat Community Rating for Spotlight Innovation (OTCMKTS STLT)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  55 (Vote Outperform)
Underperform Votes:  53 (Vote Underperform)
Total Votes:  108
MarketBeat's community ratings are surveys of what our community members think about Spotlight Innovation and other stocks. Vote "Outperform" if you believe STLT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STLT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/24/2020 by MarketBeat.com Staff

Featured Article: Treasury Bonds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel